(Q36779416)

16 August 2017

title

Production and characterization of adeno-associated viral vectors (English)

1 reference

16 August 2017

Joshua C Grieger

1 reference

16 August 2017

Vivian W Choi

series ordinal

1 reference

16 August 2017

R Jude Samulski

series ordinal

1 reference

16 August 2017

publication date

1 January 2006

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

page(s)

1412-1428

1 reference

Novel tools for production and purification of recombinant adenoassociated virus vectors

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

A helper virus-free packaging system for recombinant adeno-associated virus vectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Adeno-associated virus vectors can be efficiently produced without helper virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Factors influencing recombinant adeno-associated virus production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Cell lines for the production of recombinant adeno-associated virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Recent advances in recombinant adeno-associated virus vector production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Insect cells as a factory to produce adeno-associated virus type 2 vectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

New recombinant serotypes of AAV vectors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

AAV hybrid serotypes: improved vectors for gene delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Production of recombinant adeno-associated virus vectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Production of recombinant adeno-associated viral vectors and use for in vitro and in vivo administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Specific and efficient transduction of Cochlear inner hair cells with recombinant adeno-associated virus type 3 vector

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Characterization of the DNA of a defective human parvovirus isolated from a genital site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Clades of Adeno-associated viruses are widely disseminated in human tissues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Gene transfer into skeletal muscle using novel AAV serotypes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

7 January 2021

Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

7 January 2021

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.207

7 January 2021

Identifiers

DOI

10.1038/NPROT.2006.207

1 reference

16 August 2017

1 reference